Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Amprolium or its saltsPDL

for human use

I DEC / 13
Ampromides, their salts, derivatives and salts of derivativesN

Including: Diampromide, Phenampromide,  Propiram
 

I JUN / 02
Amrinone or its saltsPDL I DEC / 13
Amsacrine or its saltsPDL I DEC / 13
Amylocaine and its salts in preparations for topical use on mucous membranes except lozenges III SEP / 98
Amylocaine and its salts for ophthalmic or parenteral use II SEP / 98
Anabolic steroids and their derivativesC

Including: Androisoxazole; Androstanolone; Androstenediol; Bolandiol; Bolasterone; Bolazine; Boldenone; Bolenol; Calusterone; Clostebol; Drostanolone; Enestebol; Epitiostanol; Ethylestrenol; 4-Hydroxy-19-nor testosterone; Fluoxymesterone; Formebolone; Furazabol; Mebolazine; Mesabolone;  Mesterolone;  Metandienone;  Metenolone; Methandriol; Methyltestosterone; Metribolone; Mibolerone; Nandrolone; Norboletone; Norclostebol;  Norethandrolone; Oxabolone; Oxandrolone; Oxymesterone; Oxymetholone; Prasterone; Quinbolone; Stanozolol; Stenbolone; Testosterone; Tibolone; Tiomesterone; Trenbolone

I JUN / 02
Anagrelide or its saltsPDL I DEC / 13
Anakinra or its salts or derivativesPDL I DEC / 13
AnastrozolePDL I DEC / 13
AncestimPDL I DEC / 13
Anetholtrithione III SEP / 98
AnidulafunginPDL I DEC / 13
Anisotropine and its salts II SEP / 98
Antazoline and its salts III SEP / 98
Anthralin II SEP / 98
Anti-thymocyte globulinPDL I DEC / 13
Antihemophilic factor, human II SEP / 98
AntipyrinePDL

for human use, except preparations for topical use

I DEC / 13
Antipyrine.

except otic preparations

II SEP / 98
Antipyrine..

for otic use

III SEP / 98
Apalutamide or its saltsPDL I JUL / 18
Apixaban or its derivativesPDL I DEC / 13
Apomorphine or its saltsPDL I FEB / 17
Apraclonidine or its saltsPDL I DEC / 13
Apramycin or its saltsPDL I DEC / 18
ApremilastPDL I DEC / 14
Aprepitant or its derivativesPDL

including but not limited to fosaprepitant

I DEC / 13
AprotininPDL I DEC / 13
Argatroban or its salts or derivativesPDL I DEC / 13
Arginine and its salts II SEP / 98
Aripiprazole or its saltsPDL I DEC / 13
Arsenic trioxidePDL I DEC / 13
Artemisia, its preparations, extracts and compounds except in trace amounts in homeopathic preparations II SEP / 98
Asenapine or its salts or derivativesPDL

including but not limited to asenapine maleate

I DEC / 13
Asfotase alfaPDL I OCT / 15
AsparaginasePDL

when sold for administration by injection

I DEC / 13
Astemizole or its saltsPDL I DEC / 13
AsunaprevirPDL I AUG / 16
Atazanavir or its saltsPDL I DEC / 13
Atenolol or its saltsPDL I DEC / 13
AtezolizumabPDL I MAY / 17
Atipamezole or its saltsPDL I DEC / 13
Atomoxetine or its saltsPDL I DEC / 13
Atorvastatin or its saltsPDL I DEC / 13
AtovaquonePDL I DEC / 13
Atracurium besilatePDL I DEC / 13
Atropine or its saltsPDL

including but not limited to atropine sulphate, in ophthalmic or parenteral preparations

I DEC / 13
AvelumabPDL I MAR / 18
Avermectin or its derivativesPDL

including but not limited to ivermectin, selamectin, doramectin for human use

I DEC / 13
Avermectin or its derivatives.PDL

For veterinary use - including but not limited to Ivermectin, selamectin, doramectin.  Ivermectin when when recommended for intramuscular injection for horses or for oral administration to dogs and cats, except doramectin. 

 

 

I DEC / 13
Avilamycin or its salts or derivativesPDL I MAR / 14
Axicabtagene ciloleucelPDL I MAR / 19
Axitinib or its salts or derivativesPDL I DEC / 13
Azacitidine or its salts or derivativesPDL I DEC / 13
Azacyclonol or its saltsPDL I DEC / 13
AzaribinePDL I DEC / 13
Azathioprine or its saltsPDL I DEC / 13
Azatidine or its saltsPDL

including but not limited to azatadine

I DEC / 13
Azelaic acidPDL I DEC / 13
Azelastine or its saltsPDL I DEC / 14
Azilsartan medoxomil or its salts or derivativesPDL I DEC / 13
Aztreonam or its saltsPDL I DEC / 13
alpha1- proteinase inhibitor (human) I JAN / 06

164 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act